BioSpace News Archive

Business

Ellume Appoints CFO And CBO

Ellume Limited is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company.

April 24, 2019
·
2 min read
Thiazide diuretics reduced the risk of fractures in people with Alzheimer’s disease

The use of thiazide diuretics was associated with a decreased risk of low energy fractures in people with Alzheimer’s disease, a new study from the University of Eastern Finland shows.

April 24, 2019
·
1 min read
Business

CDMO Yposkesi appoints new Director of Viral Vector Manufacturing Operations

With 15 years’ bioproduction and cell & gene therapy expertise, Morad El Gueddari will take charge of Yposkesi’s industrial-scale viral vector manufacturing

April 24, 2019
·
2 min read
Yposkesi chairman Dr. Frederic Revah to speak on ‘Manufacturing and the CDMO Perspective’

Dr. Revah will join fellow industry panelists at the Cell and Gene Meeting on the Med in Barcelona to discuss strategies for gene therapy manufacturing, on April 23rd

April 24, 2019
·
2 min read
Sirio’s Ayanda launches probiotic softgel at Vitafoods Europe

Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil

April 24, 2019
·
4 min read
Cytura Therapeutics to Develop a New Class of Drugs Targeting genomic instability in cancer

Cytura Therapeutics announces the successful closure of a Seed financing round.

April 24, 2019
·
3 min read
Drug Development

Soligenix - Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials - April 23, 2019

Soligenix, Inc. issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber.

April 24, 2019
·
14 min read
Karolinska Development’s portfolio company Dilafor secures financing for continued development of tafoxiparin

Karolinska Development AB announces that its portfolio company Dilafor AB has completed a capital raising and is planning to start a new Phase 2b study of tafoxiparin to soften the cervix prior to labor induction.

April 24, 2019
·
4 min read
BioCapital

Pharma Regulatory and Pricing Updates; Sign Up for a Complimentary Inside Health Policy Trial

Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers.

April 24, 2019
·
4 min read
Biotech Beach

Arcutis, Inc. Founded to Address Gap in Immuno-Dermatology Drug Development

Arcutis, Inc., a privately held immuno-dermatology drug development company, was formed in 2016 to address significant unmet needs in dermatology.

April 24, 2019
·
4 min read